Skip to main content

Table 1 Correlation between Clinical Factors and SUVmax, SUVmean, MTV and TLG in 73 LAPC Patients

From: Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy

Clinical Factors

Cases

SUVmax

SUVmean

M (P25, P75)

z Value or

χ2 Value

P Value

M (P25, P75)

z Value or

χ2 Value

P Value

Age (yrs)

  

− 0.387

0.699

 

−0.392

0.695

  ≤ 68

38

7.0 (6.1, 9.7)

  

4.1 (3.4, 5.7)

  

 >68

35

6.6 (5.3, 10.1)

  

3.8 (3.0, 5.5)

  

Presence of DM

  

−0.533

0.594

 

−0.232

0.816

 No

58

6.9 (5.9, 10.0)

  

4.0 (3.2, 5.7)

  

 Yes

15

6.8 (5.8, 8.5)

  

4.0 (3.0, 5.3)

  

ECOG

  

0.838a

0.658

 

1.742a

0.418

 0

13

6.7 (6.4, 9.9)

  

4.0 (3.5, 5.4)

  

 1

32

7.1 (5.5, 11.3)

  

4.3 (2.9, 6.7)

  

 2

28

6.6 (5.2, 9.1)

  

3.7 (3.0, 5.2)

  

N Stage

  

−2.184

0.029

 

−1.974

0.048

 0

40

6.7 (5.6, 8.1)

  

3.7 (3.1, 4.4)

  

 1

33

8.6 (5.9, 11.2)

  

4.9 (3.3, 6.5)

  

Position

  

−0.709

0.478

 

−0.746

0.456

 Head

51

6.8 (6.0, 10.2)

  

4.1 (3.4, 5.5)

  

 Body/ Tail

22

7.0 (5.28, 9.6)

  

3.8 (3.0, 5.7)

  

The longest diameter (cm)

  

−1.353

0.176

 

−1.054

0.292

  ≤ 3.7

40

6.7 (5.8, 8.4)

  

3.9 (3.1, 5.1)

  

  > 3.7

33

7.3 (6.0, 11.1)

  

4.2 (3.1, 6.6)

  

CA 19–9 (ng/mL)

  

−0.590

0.555

 

−0.497

0.619

  ≤ 321.6

37

6.7 (5.7, 9.6)

  

4.0 (3.0, 5.4)

  

  > 321.6

36

7.1 (5.8, 10.0)

  

4.1 (3.3, 5.7)

  

Clinical Factors

Cases

MTV (cm3)

TLG (g)

M (P25, P75)

z Value or

χ2 Value

P Value

M (P25, P75)

z Value or

χ2 Value

P Value

Age (yrs)

  

−0.961

0.337

 

−0.939

0.348

  ≤ 68

38

11.3 (6.5, 19.8)

  

48.2 (29.6, 75.4)

  

 >68

35

13.2 (7.3, 27.1)

  

58.1 (33.9, 98.4)

  

Presence of DM

  

−0.608

0.543

 

0.000

1.000

 No

58

11.8 (7.3, 20.0)

  

49.0 (34.2, 85.2)

  

 Yes

15

15.9 (5.2, 35.5)

  

62.2 (25.4, 146.3)

  

ECOG

  

0.331b

0.847

 

0.063b

0.969

 0

13

12.2 (7.0, 20.5)

  

48.7 (32.3, 83.5)

  

 1

32

10.5 (5.6, 23.7)

  

51.0 (29.9, 88.9)

  

 2

28

12.6 (9.2, 25.9)

  

49.4 (34.0, 93.9)

  

N Stage

  

−1.336

0.182

 

−2.682

0.007

 0

40

12.1 (6.3, 15.7)

  

45.6 (27.9, 64.4)

  

 1

33

13.9 (7.0, 35.6)

  

67.8 (37.9, 117.1)

  

Position

  

−1.455

0.146

 

−1.353

0.176

 Head

51

11.7 (6.7, 5.9)

  

46.8 (28.6, 82.1)

  

 Body/ Tail

22

20.2 (7.8, 28.5)

  

61.1 (39.7, 99.1)

  

The longest diameter (cm)

  

−1.596

0.110

 

−2.111

0.035

  ≤ 3.7

40

10.0 (5.6, 18.9)

  

41.7 (26.0, 77.5)

  

  > 3.7

33

13.9 (8.4, 24.2)

  

64.7 (40.0, 91.3)

  

CA 19–9 (ng/mL)

  

−0.083

0.934

 

−0.535

0.593

  ≤ 321.6

37

12.6 (7.5, 17.9)

  

48.7 (32.2, 80.6)

  

  > 321.6

36

10.5 (6.4, 25.2)

  

55.4 (30.7, 92.5)

  
  1. LAPC locally advanced pancreatic cancer; SUV standardized uptake value; MTV metabolic tumor volume; TLG total lesion glycolysis; DM diabetes mellitus; ECOG Eastern Cooperative Oncology Group
  2. a, b: χ2 Value
  3. *: P < 0.05